Clinical & Public Health Guidelines
Structured comparison of authoritative cessation guidelines. Every entry records the issuing body, year, scope, key recommendations and where the guidelines differ. Sources are Tier-1: WHO, national health agencies and independent guideline bodies.
Rule: guideline positions are reported as published, with the guideline date stated. Positions are never paraphrased into stronger or weaker claims than the source makes.
Guideline comparison at a glance
| Body | Document | Year | Pharmacotherapy position | Behavioural support | E-cigarettes |
|---|---|---|---|---|---|
| WHO | Clinical treatment guideline for tobacco cessation in adults | 2024 | Recommends varenicline, NRT, bupropion, cytisine | Strongly recommended (brief advice + intensive support) | No recommendation for cessation use; evidence insufficient |
| USPSTF (US) | Tobacco Smoking Cessation in Adults, Including Pregnant Persons | 2021 | Recommends FDA-approved pharmacotherapy for nonpregnant adults (A) | Recommends behavioural interventions (A) | Evidence insufficient (I statement) |
| NICE (UK) | NG209 Tobacco: preventing uptake, promoting quitting and treating dependence | 2021 (last reviewed 2025) | Recommends varenicline, NRT, bupropion, cytisine options | Behavioural support for all, intensively for some | Nicotine-containing e-cigarettes can be offered as an aid |
| US PHS | Treating Tobacco Use and Dependence: 2008 Update | 2008 | First-line: 7 approved medications | Counseling + medication combined recommended | Predates modern evidence base |
Records
- WHO 2024 — clinical treatment guideline
- USPSTF 2021 — recommendation statement
- NICE NG209 — tobacco dependence guideline
- US PHS 2008 — Treating Tobacco Use and Dependence
How to read these records
Guidelines are statements by specific bodies at specific dates. They can and do differ — on e-cigarettes, on medication ordering, and on how strongly behavioural support is emphasized. Differences usually reflect different evidence cut-off dates, different regulatory contexts and different risk tolerances, not scientific disagreement about core facts. Where positions differ, this site states the difference rather than picking a winner.